
ivWatch, LLC: Enhancing IV therapy safety and effectiveness through innovative medical devices.
ivWatch, LLC was founded with the mission to enhance the safety and effectiveness of intravenous (IV) therapy through innovative medical devices. The company's core product, the ivWatch Monitoring System, provides continuous monitoring to detect IV infiltrations and extravasations early, even when physical signs are not visible. This technology aims to reduce negative patient events, improve response times, and support healthcare teams in delivering optimal patient care.
Notable affiliated individuals and investors include key figures in the medical device and biosensor industries, although specific names are not provided. ivWatch has achieved significant milestones in improving patient safety and clinical outcomes, positioning itself as a leader in IV therapy monitoring. The company's impact is evident in its ability to provide critical insights into patients' IV status, thereby enhancing overall healthcare delivery.

I-V Access Technology
ivatinc.com

ICU Medical
icumed.com

Vasc-Alert
vasc-alert.com

Vivalink
vivalink.com

Invisalert Solutions
observsmart.com

Injectsense
injectsense.com

IntraVu
intravu.com

S.E.A. Medical Systems
seamedical.com

AccuVein
accuvein.com

Vasowatch
vasowatch.com

Volumetrix
volumetrix.com

IVX Health
ivxhealth.com

InterVene
intervene-med.com

Octovis

Evena Medical
evenamed.com
Companies similar to ivWatch include I-V Access Technology, ICU Medical, Vasc-Alert and Vivalink.
ivWatch was founded in 2010.
ivWatch's headquarters is located in Hampton, VA, US.
ivWatch's most recent funding round was for $1.5M (USD) in July 2020.
As of Jul 6, 2020, ivWatch has raised a total of $35.1M (USD).
ivWatch has 55 employees as of Feb 5, 2024.